60 Degrees Pharmaceuticals (SXTP) Interest & Investment Income (2023 - 2026)
60 Degrees Pharmaceuticals' (SXTP) quarterly Interest & Investment Income came in at $5516.0 in Q2 2026, up 104.29% year-over-year from $2700.1 in Q2 2025, and up 14.77% quarter-over-quarter from $4806.0 in Q1 2026.
Powered by 
Analysis
60 Degrees Pharmaceuticals (SXTP) Interest & Investment Income (2023 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Interest & Investment Income for 4 consecutive years, with $5516.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest & Investment Income rose 104.29% year-over-year to $5516.0 in Q2 2026; TTM through Jun 2026 was -$109541.0, a 9.4% increase from a year earlier, with the FY2024 full-year figure at $1.8 million, up 31.21% from the prior year.
- Interest & Investment Income was $5516.0 for Q2 2026 at 60 Degrees Pharmaceuticals, up from $4806.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $5.7 million in Q3 2023 and troughed at -$151995.0 in Q4 2023.
- A 4-year average of $656998.7 and a median of $8739.0 in 2025 frame the typical range for Interest & Investment Income.
- The widest YoY moves for Interest & Investment Income: up 121.03% in 2025, down 959.52% in 2025.
- Over 4 years, Interest & Investment Income stood at -$151995.0 in 2023, then jumped by 110.27% to $15616.0 in 2024, then sank by 44.04% to $8739.0 in 2025, then tumbled by 36.88% to $5516.0 in 2026.
- The last three Interest & Investment Income figures came in at $5516.0 (Q2 2026), $4806.0 (Q1 2026), and $8739.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.73 Bn | 39.07 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.04 Bn | 18.16 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.81 Bn | 9.64 Bn | 396.53 Mn | 31.57 Mn |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.34 Bn | 334.51 Mn | -55.04 Mn |
| 5 | Bausch Health Companies | 2.28 Bn | 440.12 Mn | 2.10 Bn | 11.00 Mn |
| 6 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | -3.64 Mn |
| 7 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -16.41 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 710.20 Mn | 93.47 Mn | 2.29 Mn |
| 9 | Fennec Pharmaceuticals | 398.99 Mn | 357.75 Mn | 17.15 Mn | 287,000.00 |
| 10 | 60 Degrees Pharmaceuticals | 2.47 Mn | 1.45 Mn | 56,798.00 | 5,516.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,516.00 |
| Mar 31, 2026 | 4,806.00 |
| Sep 30, 2025 | 8,739.00 |
| Jun 30, 2025 | -128,602.00 |
| Mar 31, 2025 | 33,637.00 |
| Dec 31, 2024 | 15,616.00 |
| Sep 30, 2024 | -41,556.00 |
| Jun 30, 2024 | 14,962.00 |
| Mar 31, 2024 | 1.77 Mn |
| Dec 31, 2023 | -151,995.00 |
| Sep 30, 2023 | 5.70 Mn |